Clinical Trials Logo
  1. Home
  2. Alcohol Abuse
  3. NCT01511679
  4. Details
NCT01511679 Clinical Trial

Brain-imaging and Adolescent Neuroscience Consortium

Alcohol Abuse Clinical Trial

— BANC  

Official title:
Brain-imaging and Adolescent Neuroscience Consortium

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT01511679
Other study ID # BANC RFA-AA-12-006
Secondary ID
Status Withdrawn
Phase N/A
First received January 13, 2012
Last updated January 2, 2013
Start date September 2012
Est. completion date September 2017

Study information
Verified date January 2013
Source Children's Hospital Boston
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This is a multi-site study of adolescents 12-21 years-of-age to evaluate the long and shorter-term effect of adolescent alcohol use on the developing brain.

Description:

The overall specific aims of this study are to: 1) assess the short and long-term consequences of alcohol exposure on brain, cognitive, and emotional/regulatory development during preadolescence and adolescence; 2) determine the effects of timing, dose, and duration of alcohol on brain and cognitive development; 3) assess recovery of neural and behavioral function to determine if the plasticity of the adolescent brain makes it more or less vulnerable to alcohol's acute and chronic effects; 4) understand how other key covariates (e.g., existing or emerging psychopathology, family history of alcoholism, demographics, pubertal development) factor into alcohol's effects on the brain; and 5) identify early neural, cognitive, and affective markers that may predict alcohol abuse and dependence during adolescence and/or adulthood.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date September 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 21 Years
Eligibility Inclusion Criteria:

- able to read and understand English

- available for follow-up

- parental consent/adolescent assent for those 12-17 years

- consent for those 18-21 years

Exclusion Criteria:

- Weight > 300 lbs

- braces or unremovable embedded metal

- claustrophobia or inability to lie still in MRI machine

- current or past 12-mos pregnancy (females)

- requires urgent medical/mental health care

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
United States McLean Hospital Belmont Massachusetts
United States Boston University School of Medicine Boston Massachusetts
United States Massachusetts General Hospital Boston Massachusetts
United States Massachusetts Institute of Technology Cambridge Massachusetts

Sponsors (4)
Lead Sponsor Collaborator
Children's Hospital Boston Massachusetts General Hospital, Massachusetts Institute of Technology, Mclean Hospital

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT03165942 - Neuroendocrine Response to Oral Alcohol Administration Phase 1
Recruiting NCT05343039 - Technology Enhanced Adolescent Mental Health (TEAM) N/A
Active, not recruiting NCT04070521 - EEG Monitoring in the Emergency Department
Completed NCT03169244 - Buproprion for Binge Drinking Phase 2
Completed NCT05036499 - PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain N/A
Recruiting NCT04368416 - Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
Not yet recruiting NCT04557631 - Evaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol
Terminated NCT00890149 - Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults Phase 2
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Completed NCT02681406 - Smartphone Based Continuing Care for Alcohol N/A
Completed NCT02448134 - A Community-Based Strategy for Preventing Underage Drinking N/A
Withdrawn NCT01796158 - Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use N/A
Withdrawn NCT01847300 - cSBI-M for Young Military Personnel N/A
Completed NCT01553136 - Varenicline Treatment of Alcohol Dependence in Smokers Phase 2
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Withdrawn NCT01275391 - cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use Phase 1/Phase 2
Active, not recruiting NCT01539525 - Screening to Augment Referral to Treatment- Project START Phase 2
Completed NCT01207258 - Brief Intervention for Problem Drinking and Partner Violence Phase 2
Completed NCT00907309 - Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use Phase 1/Phase 2
Completed NCT01518972 - Prazosin for Alcohol Dependence and Posttraumatic Stress Disorder Phase 2

External Links